ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Ramón Salazar(Institut Català d'Oncologia), Martin Anlauf(Kiel University), Anne Couvelard(Délégation Paris 7), Éric Baudin(Institut Gustave Roussy), Kjell Öberg(Uppsala University Hospital), Thomas Steinmüller(DRK Kliniken Berlin), Bertram Wiedenmann(Charité - Universitätsmedizin Berlin), Eric P. Krenning(Cyclotron (Netherlands))
Cited by 869
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863